Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_assertion type Assertion NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_head.
- NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_assertion description "[We also identified novel recurrent mutations in the AR collaborating factor FOXA1, which is mutated in 5 of 147 (3.4%) prostate cancers (both untreated localized prostate cancer and CRPC), and showed that mutated FOXA1 represses androgen signalling and increases tumour growth.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_provenance.
- NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_assertion evidence source_evidence_literature NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_provenance.
- NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_assertion SIO_000772 22722839 NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_provenance.
- NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_assertion wasDerivedFrom befree-2016 NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_provenance.
- NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_assertion wasGeneratedBy ECO_0000203 NP992092.RAYupwgU7bYCbp1O91UkDpRQ_9oAbW9WMgTx0Rovy-_WI130_provenance.